Osteogenic Mechanisms in Age-Related Osteoporosis

Age-related osteoporosis arises from a progressive decline in the capacity of bone to form new tissue, leading to net bone loss and increased fracture risk. Central to this process is the disruption of osteoblastogenesis—the differentiation of mesenchymal stem cells into bone-forming osteoblasts—and a relative increase in bone marrow adiposity. With advancing age, osteoprogenitor cells accumulate senescent markers and exhibit diminished responsiveness to key osteogenic signals such as Wnt, bone morphogenetic proteins and insulin-like growth factors. Concurrently, the bone marrow niche becomes enriched in adipocytes, further biasing mesenchymal precursors away from the osteoblastic lineage and impairing matrix deposition. Inflammatory mediators arising from systemic “inflammaging” alter the coupling between osteoblasts and osteoclasts, exacerbating bone resorption. Epigenetic modifications, altered mechanotransduction and shifts in local growth factor availability also contribute to impaired bone quality. Together, these intersecting processes underpin the age-related imbalance in bone remodelling that characterises osteoporosis, with profound implications for global health and the prevention of fragility fractures.

Research from Nature Portfolio

Recent studies have demonstrated a novel approach to generate functional osteoblast-like cells via direct transdifferentiation of human dermal fibroblasts using platelet lysate. This method bypasses pluripotent intermediates and yields cells expressing key osteogenic markers, depositing mineralised matrix and exhibiting alkaline phosphatase activity. Transcriptomic profiling of transdifferentiated cells reveals upregulation of skeletal development programmes and bone mineralisation pathways, indicating a stable osteogenic phenotype. Such an in vitro model offers a patient-derived platform to investigate osteoblast-dependent disorders and screen bone-targeted therapeutics without requiring primary bone biopsies.

Osteogenic Mechanisms in Age-Related Osteoporosis publication trend

The graph below shows the total number of articles in osteogenic mechanisms in age-related osteoporosis across all publications each year (not limited to Nature Index journals).

Technical terms

Osteoblastogenesis: The process by which mesenchymal stem cells differentiate into osteoblasts, the specialised cells responsible for new bone formation.

Bone marrow adiposity (BMA): The accumulation of fat cells within the bone marrow cavity, which can displace osteoprogenitors and impair bone formation.

Transdifferentiation: The direct conversion of one differentiated cell type into another without passing through a pluripotent state.

Platelet-derived biomaterials: Preparations of concentrated platelets, such as platelet-rich plasma and fibrin, that release growth factors promoting tissue repair and regeneration.

References

1. The Potential Therapeutic Effects of Platelet‐Derived Biomaterials on Osteoporosis: A Comprehensive Review of Current Evidence. International Journal of Biomaterials (2023).
2. The pathophysiology of osteoporosis in obesity and type 2 diabetes in aging women and men: The mechanisms and roles of increased bone marrow adiposity. Frontiers in Endocrinology (2022).
3. Novel transplant of combined platelet-rich fibrin Releasate and bone marrow stem cells prevent bone loss in Ovariectomized osteoporotic mice. BMC Musculoskeletal Disorders (2020).
4. Osteogenic transdifferentiation of primary human fibroblasts to osteoblast-like cells with human platelet lysate. Scientific Reports (2022).